drugset / Trial / NCT07828639

A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo

NCT07828639 ↗

Phase 1/2 Not yet recruiting 10 enrolled Jiangsu vcare pharmaceutical technology co., LTD
NaSingle-groupOpen-labelTreatment

Summary

This study is a multicenter, open-label, non-randomized study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with Non-Segmental Vitiligo

Timeline

Start
2026-09-25
Primary completion
2027-05-30
Completion
2027-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject VC005 Unknown — —

Indications